# Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

> **NCT06286878** · PHASE2,PHASE3 · RECRUITING · sponsor: **University of Sao Paulo** · enrollment: 80 (estimated)

## Conditions studied

- Myocardial Infarction
- Acute Coronary Syndrome
- Diabetes
- Ventricular Dysfunction

## Interventions

- **DRUG:** Placebo
- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT06286878
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-08
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06286878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06286878, "Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06286878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*